Intravitreal gas of little value in early macular hole
Intravitreal expansile gas is not effective in most cases with early macular hole, according to a prospective study involving 122 patients. The patients in the study all had early, stage 2 macular holes and underwent intravitreal injection of perfluoropropane 0.2ml followed by five days' facedown positioning. The study's investigators found that only three cases (25 per cent) had hole closure with vision improvement, and of those, one developed rhegmatogenous retinal detachment (RRD) and hole re-opening. Another case with persistent hole also developed RRD. In contrast, in seven of the nine cases without hole closure and the one where the hole re-opened had vitrectomy, all had hole closure and vision improvement.
(Chen et al, Ophthalmologica 2012 DOI: 10.1159/000337840.)Â
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.